Jackob Moskovitz

Jackob Moskovitz

Mar 06, 2019

Group 6 Copy 161
1
Please wait...

About This Project

Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

Blast off!

Browse Other Projects on Experiment

Related Projects

Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?

Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant bacteria...

Can We Defeat EBOLA with an Experimental CANCER Drug?

The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and...

Activating brown fat to improve diabetes and obesity

Diabetes in childhood is life changing, needing daily insulin injections to get strict blood sugar control...

Campaign Ended

A medicine project funded by 45 people